Quote in 15 min·24/7 × 365AS9120:2025 · ISO 9001:2015 · FAA AC 00-56B
NSN 6505-01-353-9847CAGE U9F24
NDC00187-0798-42
Diltiazem Extended Release Capsu
Diltiazem Extended Release Capsu ASAP can help source this line with documentation review, alternate part checks, condition requirements, and account manager follow-up for urgent or planned procurement.
Valeant Pharmaceuticals
Manufacturer
USA
Origin
N/A
Spec
N/A
Unit weight
Detailed description
Technical sourcing notes
N/A
Lead time
N/A
Cross references
Unrestricted
Export control
6505 Drugs and Biologicals
FSC
Why ASAP
Operations-grade aviation sourcing.
AS9120B
Quality-managed distribution
15 min
Average RFQ response, 24/7
Full trace
Documentation & certs on request
Submit RFQ
Request a quote for NDC00187-0798-42
Send this part to ASAP with quantity, need-by timing, and buyer contact details. An account manager will review availability, alternates, certificates, and delivery options.
Part-specific RFQ
Submit RFQ for NDC00187-0798-42
Send this part to ASAP with quantity, need-by timing, and buyer contact details. A dedicated account manager reviews availability, alternates, certificates, and delivery options.
Diltiazem Extended Release CapsuNDC00187-0798-42
NSN6505-01-353-9847
- Manufacturer
- Valeant Pharmaceuticals
- CAGE
- U9F24
NSN Information for Part Number NDC00187-0798-42 with NSN 6505-01-353-9847, 6505013539847
Characteristics Data of NSN 6505-01-353-9847, 6505013539847
| MRC | Criteria | Characteristic |
|---|---|---|
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 300.000 MILLIGRAMS DILTIAZEM HYDROCHLORIDE ACTIVE INGREDIENT |
| AKJC | CAPSULE TYPE | ANY ACCEPTABLE |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CQLS | CAPSULE CONTENT FORM | ANY ACCEPTABLE |
| CXCY | III PART NAME ASSIGNED BY CONTROLLING AGENCY | DILTIAZEM EXTENDED-RELEASE CAPSULES USP 300MG 90S BT |
| CYLZ | CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 90.000 |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| THPE | THERAPEUTIC EQUIVALENT | TO CARDIZEM-CD BY MARION MERRELL DOW |
